Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Caligan Partners LP | 7.97M | $31.0M | 9.54% | -- | 2026-06-30 |
| Vivo Capital, LLC | 7.30M | $28.0M | 8.74% | -4.12M | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 6.63M | $25.0M | 7.94% | +195.8K | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.41M | $24.0M | 7.67% | +3.00M | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 4.40M | $17.0M | 5.27% | -- | 2026-06-30 |
| Balyasny Asset Management L.P. | 3.76M | $14.0M | 4.50% | -- | 2026-06-30 |
| BlackRock, Inc. | 3.07M | $11.0M | 3.67% | +2.76M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.97M | $11.0M | 3.56% | +479.2K | 2026-06-30 |
| Commodore Capital LP | 2.87M | $11.0M | 3.44% | -1.53M | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 2.75M | $10.0M | 3.29% | -283.6K | 2026-06-30 |
